SLGL

Sol Gel Technologies Ltd

SLGL, USA

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

https://www.sol-gel.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
SLGL
stock
SLGL

Revenues Not Telling The Story For Sol-Gel Technologies Ltd. (NASDAQ:SLGL) After Shares Rise 30% simplywall.st

Read more →
SLGL
stock
SLGL

Major Shareholder Makes Strategic Move with Sol-Gel Technologies Stock! TipRanks

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$50

Analyst Picks

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

4.17

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-22.83 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-17.18 %

Low ≤ 2%

High ≥ 10%

Debt to Equity

-

Very High

0.33

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 18.90% of the total shares of Sol Gel Technologies Ltd

1.

Phoenix Financial Ltd

(17.7343%)

since

2025/06/30

2.

Yelin Lapidot Holdings Management Ltd

(0.6373%)

since

2025/06/30

3.

UBS Group AG

(0.2634%)

since

2025/06/30

4.

Morgan Stanley - Brokerage Accounts

(0.1915%)

since

2025/06/30

5.

Fidelity Nasdaq Composite Index

(0.0481%)

since

2025/07/31

7.

BlackRock Inc

(0.0111%)

since

2025/06/30

8.

SBI Securities Co Ltd

(0.0036%)

since

2025/06/30

9.

SIMPLEX TRADING, LLC

(0.0009%)

since

2025/03/31

10.

Bank of America Corp

(0.0004%)

since

2025/06/30

11.

Hanson Mcclain Inc

(0.0002%)

since

2025/06/30

12.

CALIBER WEALTH MANAGEMENT, LLC

(0%)

since

2025/06/30

13.

Ground Swell Capital, LLC

(0%)

since

2025/06/30

14.

Cetera Investment Advisers

(0%)

since

2025/03/31

15.

Wells Fargo & Co

(0%)

since

2025/06/30

18.

Citadel Advisors Llc

(0%)

since

2025/06/30

19.

BNP Paribas Arbitrage, SA

(0%)

since

2025/06/30

20.

Geode Capital Management, LLC

(0%)

since

2025/06/30

21.

Two Sigma Investments LLC

(0%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.4

Latest Release

Date

2025-09-30

EPS Actual

-2.13

EPS Estimate

-0.9

EPS Difference

-1.23

Surprise Percent

-136.6667%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(3)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(1.5)
Momentum
Moderate Momentum(4.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(2.5)
Value
Overpriced(3)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.